圆壹智慧是一家拥有快速、自主进化的AI药物设计平台的新一代生物技术公司。其第三代AI系统为小分子、抗体和其他复杂治疗方式提供极速虚拟筛选和多目标药理学优化的解决方案。该平台能在几小时内计算筛选多达10的十次方个蛋白质序列或化合物，最终筛选出的候选化合物，其实验验证率显著高于传统方法所得，极大缩短了发现周期和成本。详情请访问ainnocence.cn。
Ainnocence is a next-generation biotech company with a fast, self-evolving AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for small-molecule, antibody, and other complex therapeutic modalities. This platform provides a computational screening capacity of up to 10^10 protein sequences or chemical compounds within hours. The end results are a shortlist of candidates with a very high wet-lab hit rate, and a dramatically reduced discovery time and cost. To learn more, visit ainnocence.com.